You are here

  • Home
  • Archive
  • Volume 57, Issue 5
  • Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model

Citation Tools

Article menu
Download PDFPDF
Pancreas
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Vallera DA, Stish BJ, Shu Y, et al
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model
Gut 2008;57:634-641.